Off-label intravitreal brolucizumab for recalcitrant diabetic macular edema: A real-world case series

Off-label intravitreal brolucizumab for recalcitrant diabetic macular edema: A real-world case series

Purpose: To report the efficacy of intravitreal injection (IVI) of brolucizumab for recalcitrant diabetic macular edema (DME) in a real-world setting. Observations: This was a single-center, prospective uncontrolled non-randomized case series. Three eyes with recalcitrant DME, who have received a mi...

Full description

Bibliographic Details
Main Authors: Debdulal Chakraborty, Jay U. Sheth, Subhendu Boral, Tushar K. Sinha
Format: Article
Language:English
Published: Elsevier 2021-12-01
Series:American Journal of Ophthalmology Case Reports
Subjects:
Brolucizumab
Diabetic macular edema
Anti-vascular endothelial growth factor
Online Access:http://www.sciencedirect.com/science/article/pii/S2451993621002061

Similar Items

Similar Items